BeiGene, Ltd. announced the groundbreaking of its U.S. manufacturing and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J. The initial phase of construction is expected to include approximately 400,000 square feet of dedicated commercial-stage biologic pharmaceutical manufacturing space, with capacity for up to 16,000 liters of biologics formula. BeiGene intends to recruit hundreds of new hires from the area's attractive talent market to support its continued growth and its commitment to producing life-saving oncology medicines. BeiGene currently has five offices in the U.S., in San Mateo and Emeryville, Calif., Cambridge, Mass., Ridgefield Park, N.J. and Fulton, Md.

Globally, the company has more than 30 offices across five continents.